Liver Unit, Hospital Clínic Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain.
Institute of Liver Studies, King's College Hospital, MRC Transplant Centre, King's College London University, London, England, United Kingdom.
J Hepatol. 2018 Sep;69(3):626-634. doi: 10.1016/j.jhep.2018.04.012. Epub 2018 Apr 28.
BACKGROUND & AIMS: Subclinical inflammatory changes are commonly described in long-term transplant recipients undergoing protocol liver biopsies. The pathogenesis of these lesions remains unclear. The aim of this study was to identify the key molecular pathways driving progressive subclinical inflammatory liver allograft damage.
All liver recipients followed at Hospital Clínic Barcelona who were >10 years post-transplant were screened for participation in the study. Patients with recurrence of underlying liver disease, biliary or vascular complications, chronic rejection, and abnormal liver function tests were excluded. Sixty-seven patients agreed to participate and underwent blood and serological tests, transient elastography and a liver biopsy. Transcriptome profiling was performed on RNA extracted from 49 out of the 67 biopsies employing a whole genome next generation sequencing platform. Patients were followed for a median of 6.8 years following the index liver biopsy.
Median time since transplantation to liver biopsy was 13 years (10-22). The most frequently observed histological abnormality was portal inflammation with different degrees of fibrosis, present in 45 biopsies (67%). Two modules of 102 and 425 co-expressed genes were significantly correlated with portal inflammation, interface hepatitis and portal fibrosis. These modules were enriched in molecular pathways known to be associated with T cell mediated rejection. Liver allografts showing the highest expression levels for the two modules recapitulated the transcriptional profile of biopsies with clinically apparent rejection and developed progressive damage over time, as assessed by non-invasive markers of fibrosis.
A large proportion of adult liver transplant recipients who survive long-term exhibit subclinical histological abnormalities. The transcriptomic profile of these patients' liver tissue closely resembles that of T cell mediated rejection and may result in progressive allograft damage.
A large proportion of adult liver transplant recipients who survive for a long time exhibit subclinical histological abnormalities. The expression profile (a measurement of the activity of genes) of liver tissue from a large fraction of these patients closely resembles the profile of T cell mediated rejection. Liver allografts showing the highest expression levels of rejection-related genes developed progressive damage over time.
在接受方案性肝活检的长期移植受者中,常描述亚临床炎症变化。这些病变的发病机制尚不清楚。本研究的目的是确定导致进行性亚临床炎症性肝移植物损伤的关键分子途径。
筛选了在巴塞罗那 Clinic 医院接受移植后 >10 年的所有肝移植受者,以参与该研究。排除了有基础肝病复发、胆道或血管并发症、慢性排斥反应和肝功能检查异常的患者。67 例患者同意参与并接受了血液和血清学检查、瞬时弹性成像和肝活检。对 67 例肝活检中的 49 例采用全基因组下一代测序平台进行 RNA 转录组分析。在指数肝活检后,对患者进行了中位数为 6.8 年的随访。
肝活检距移植时间中位数为 13 年(10-22 年)。最常观察到的组织学异常是不同程度纤维化的门脉炎症,存在于 45 例活检中(67%)。两个由 102 和 425 个共表达基因组成的模块与门脉炎症、界面肝炎和门脉纤维化显著相关。这些模块富含与 T 细胞介导的排斥反应相关的已知分子途径。表现出两个模块最高表达水平的肝移植物再现了具有临床明显排斥的活检的转录谱,并随着时间的推移,通过纤维化的非侵入性标志物进展为进行性损伤。
很大一部分长期存活的成人肝移植受者表现出亚临床组织学异常。这些患者肝组织的转录组谱与 T 细胞介导的排斥反应非常相似,可能导致进行性移植物损伤。
巴塞罗那 Clinic 医院
研究人员对 67 名肝移植受者进行了血液和血清学检查、瞬时弹性成像和肝活检,对其中 49 例肝活检组织进行了 RNA 转录组分析,并对这些患者进行了中位数为 6.8 年的随访。
患者的生存时间、肝活检组织的组织学异常、基因表达谱、非侵入性标志物的纤维化程度。
研究发现,很大一部分长期存活的成人肝移植受者表现出亚临床组织学异常,这些患者肝组织的转录组谱与 T 细胞介导的排斥反应非常相似,可能导致进行性移植物损伤。
长期存活的肝移植受者中,很大一部分存在亚临床组织学异常,这些患者的肝组织转录组谱与 T 细胞介导的排斥反应相似,可能导致进行性移植物损伤。